Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. FDA Envisions Many Regulatory Coalitions Dealing With Globalization Issues

This article was originally published in PharmAsia News

Executive Summary

U.S. FDA could help create several international coalitions to carry out its new globalization plan, which could allow for issue-specific groups focused on individual pharmaceutical sectors

You may also be interested in...



Mylan Grabs More FDA Globalization Talent

Steve Lynn, director of CDER’s Office of Manufacturing and Product Quality, will take an executive global compliance position.

U.S. FDA To Close Office In Amman, Jordan; Says It Is Still Committed To MENA Region

Opened as part of the globalization initiative, U.S. FDA’s presence in the Middle East and North Africa will shut down in late December in an apparent cost-cutting effort.

FDA Inspection Growth In China Stymied By Visa Issues

The agency is waiting for approval to locate 10 new drug inspectors in China.

Related Content

UsernamePublicRestriction

Register

OM014079

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel